2. In these Regulations, unless the context otherwise requires —| “application fee” means the applicable application fee specified in the Fifth Schedule to the Health Products (Fees) Regulations 2022 (G.N. No. S 450/2022); [S 455/2022 wef 01/07/2022] |
| “approved conveyance”, “approved permanent premises” and “permanent premises” have the meanings given by section 2(1) of the Healthcare Services Act 2020; [S 433/2023 wef 26/06/2023] |
| “Authority’s website” means the Authority’s Internet website at http://www.hsa.gov.sg; |
| “collaborative prescribing practitioner” has the meaning given by regulation 2 of the Healthcare Services (Collaborative Prescribing Service) Regulations 2023 (G.N. No. S 398/2023); [S 433/2023 wef 26/06/2023] |
| “CTGT product” means a health product categorised as a cell, tissue or gene therapy product in the First Schedule to the Act; [S 106/2021 wef 01/03/2021] |
“dispense”, in relation to a therapeutic product, means to prepare and supply the therapeutic product to a patient, where the preparation and supply is made by —| (a) | a qualified practitioner or collaborative prescribing practitioner, or a person acting under the supervision of a qualified practitioner or collaborative prescribing practitioner; or [S 120/2018 wef 01/03/2018] | | (b) | a qualified pharmacist or a person acting under the supervision of a qualified pharmacist; |
|
| “general sale list medicine” means a therapeutic product registered under the classification of “general sale list medicine” in the Register of Health Products; |
| “healthcare service licensee” means a person who holds a licence under the Healthcare Services Act 2020 to provide a licensable healthcare service; [S 433/2023 wef 26/06/2023] |
“in-store pharmaceutical officer” means —| (a) | a qualified pharmacist engaged or employed to provide pharmacy services at or from a retail pharmacy specified in a pharmacy licence; or | | (b) | a person acting under the supervision of the qualified pharmacist mentioned in paragraph (a), when providing pharmacy services at or from the retail pharmacy mentioned in that paragraph; |
|
| [Deleted by S 433/2023 wef 26/06/2023] |
| “licensable healthcare service” has the meaning given by section 3(1) of the Healthcare Services Act 2020; [S 433/2023 wef 26/06/2023] |
| [Deleted by S 808/2023 wef 18/12/2023] |
| [Deleted by S 808/2023 wef 18/12/2023] |
| “oral dental gum” means a health product categorised as an oral dental gum in the First Schedule to the Act; |
| “personnel”, in relation to a healthcare service licensee providing a licensable healthcare service, means any individual employed or engaged by the healthcare service licensee to assist the licensee in providing the licensable healthcare service; [S 808/2023 wef 18/12/2023] |
| “pharmacy department”, in relation to a healthcare service licensee, means the part of any approved permanent premises, approved conveyance or temporary premises of the healthcare service licensee set aside for the supply, dispensing or compounding of therapeutic products on order or prescription to patients at the approved permanent premises, approved conveyance or temporary premises; [S 808/2023 wef 18/12/2023] |
| “pharmacy licence” means a licence, issued by the Authority under these Regulations, to carry on a retail pharmacy business at or from the retail pharmacy specified in the licence; |
“qualified pharmacist” means a person who —| (a) | is registered as a pharmacist under the Pharmacists Registration Act 2007; [S 433/2023 wef 31/12/2021] | | (b) | holds a valid practising certificate granted under section 23 of that Act; and | | (c) | is in active practice as defined in regulation 2 of the Pharmacists Registration (Practising Certificates) Regulations 2008 (G.N. No. S 438/2008); |
|
“qualified practitioner” means —| (a) | a registered medical practitioner under the Medical Registration Act 1997; or [S 433/2023 wef 31/12/2021] | | (b) | a registered dentist under the Dental Registration Act 1999 whose name appears in the first division of the Register of Dentists maintained and kept under section 13(1)(a) of that Act; [S 433/2023 wef 31/12/2021] |
|
| “retail pharmacy” means any premises at or from which a retail pharmacy business is or is to be conducted, and excludes a pharmacy department; |
| “retail pharmacy business” means a business (not being a professional practice carried out by a qualified practitioner or collaborative prescribing practitioner) that consists of or includes the provision of retail pharmacy services to the general public; [S 120/2018 wef 01/03/2018] |
| “retail pharmacy services” means the sale or dispensing of one or more specified health products, whether or not accompanied by advice or counselling on the effective and safe use of those products; |
| “specified health product” means a health product specified in the First Schedule; |
| “telepharmacy services” means the provision of retail pharmacy services by a qualified pharmacist at a retail pharmacy, through a computer, or video or audio link; [S 106/2021 wef 01/03/2021] |
| “temporary premises” means any premises other than permanent premises; [S 433/2023 wef 26/06/2023] |
| “therapeutic product” means a health product categorised as a therapeutic product in the First Schedule to the Act. |
|